Alpha-1 antitrypsin promotes re-epithelialization by regulating inflammation and migration.

Area of Science:

• Wound healing research
• Immunology
• Cell biology

Background:

• Efficient wound healing requires precise regulation of inflammation and re-epithelialization.
• Human alpha1-antitrypsin (hAAT) is an established immunomodulatory protein with potential therapeutic applications.

Purpose of the Study:

• To investigate the role of hAAT in modulating inflammation and promoting re-epithelialization in epithelial cells.
• To assess the effects of hAAT on epithelial cell migration and wound closure in vitro and in vivo models.

Main Methods:

• Utilized in vitro epithelial gap closure and migration assays with HaCaT and A549 cells.
• Administered topical hAAT treatment to mice with induced corneal abrasions for in vivo studies.
• Analyzed gene and protein expression of inflammatory markers and adhesion molecules using qPCR and immunohistochemistry.

Main Results:

• hAAT accelerated epithelial gap closure and migration in vitro, independent of proliferation.
• In vivo, hAAT treatment enhanced corneal wound closure and modulated inflammatory marker expression (IL-1Ra over IL-1β).
• hAAT upregulated key adhesion molecules (desmoglein-1, plectin, integrin α6β4) in both in vitro and in vivo models.

Conclusions:

• hAAT significantly enhances re-epithelialization processes.
• The mechanism involves modulation of inflammation and promotion of epithelial cell migration.
• hAAT regulates the expression of critical adhesion molecules involved in tissue repair.